The ADVATx is the world's only 589-nm/1319-nm dual-wavelength laser technology with 25 FDA/CE-cleared indications, no consumables, no social downtime for the patient, and a comprehensive warranty and marketing support service for the provider. The ADVATx is available globally through parent company Advalight, headquartered in Copenhagen, Denmark, and has sales and service offered through its U.S. subsidiary office in San Diego.